{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:54:24Z","timestamp":1790387664565,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T00:00:00Z","timestamp":1423612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00277-015-2308-0","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T01:24:59Z","timestamp":1423531499000},"page":"955-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis"],"prefix":"10.1007","volume":"94","author":[{"given":"Jia","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,11]]},"reference":[{"issue":"7","key":"2308_CR1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-136-7-200204020-00011","volume":"136","author":"NS Young","year":"2002","unstructured":"Young NS (2002) Acquired aplastic anemia. Ann Intern Med 136(7):534\u2013546","journal-title":"Ann Intern Med"},{"issue":"1","key":"2308_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","volume":"92","author":"A Locasciulli","year":"2007","unstructured":"Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A et al (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92(1):11\u201318","journal-title":"Haematologica"},{"issue":"8","key":"2308_CR3","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","volume":"108","author":"NS Young","year":"2006","unstructured":"Young NS, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108(8):2509\u20132519","journal-title":"Blood"},{"issue":"4","key":"2308_CR4","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2002-04-1134","volume":"101","author":"N Frickhofen","year":"2003","unstructured":"Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101(4):1236\u20131242","journal-title":"Blood"},{"issue":"9","key":"2308_CR5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","volume":"289","author":"S Rosenfeld","year":"2003","unstructured":"Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130\u20131135","journal-title":"JAMA"},{"issue":"5","key":"2308_CR6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO et al (2011) A randomized trial of horse versus rabbit antithymocyte globulin in severe acquired aplastic anemia. N Engl J Med 365(5):430\u2013438","journal-title":"N Engl J Med"},{"issue":"6","key":"2308_CR7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00277-013-1688-2","volume":"92","author":"S Heublein","year":"2013","unstructured":"Heublein S, Wehner F, Hochsmann B, Hochhaus A, Hartmann M, La Rosee P (2013) Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany. Ann Hematol 92(6):825\u2013830","journal-title":"Ann Hematol"},{"issue":"23","key":"2308_CR8","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","volume":"119","author":"JC Marsh","year":"2012","unstructured":"Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR et al (2012) Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood 119(23):5391\u20135396","journal-title":"Blood"},{"issue":"1","key":"2308_CR9","first-page":"38","volume":"32","author":"HM Cao","year":"2011","unstructured":"Cao HM, Wang HJ, Zhang L, Jing LP, Zhou K, Yang DL et al (2011) Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia. Zhonghua Xue Ye Xue Za Zhi 32(1):38\u201342","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"7","key":"2308_CR10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00432-012-1184-4","volume":"138","author":"C Chen","year":"2012","unstructured":"Chen C, Xue HM, Xu HG, Li Y, Huang K, Zhou DH et al (2012) Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia. J Cancer Res Clin Oncol 138(7):1105\u20131111","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"2308_CR11","doi-asserted-by":"crossref","first-page":"e56648","DOI":"10.1371\/journal.pone.0056648","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Shi J, Ge M, Shao Y, Huang J, Huang Z et al (2013) Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience. PLoS One 8(3):e56648","journal-title":"PLoS One"},{"issue":"5","key":"2308_CR12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cyto.b.20519","volume":"78","author":"M Battiwalla","year":"2010","unstructured":"Battiwalla M, Hepgur M, Pan D, McCarthy PL, Ahluwalia MS, Camacho SH et al (2010) Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations. Cytometry B Clin Cytom 78(5):348\u2013356","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"2308_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2257.2001.00357.x","volume":"23","author":"U Oelschlaegel","year":"2001","unstructured":"Oelschlaegel U, Besson I, Arnoulet C, Sainty D, Nowak R, Naumann R et al (2001) A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes. Clin Lab Haematol 23(2):81\u201390","journal-title":"Clin Lab Haematol"},{"issue":"2","key":"2308_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hoc.2009.01.005","volume":"23","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Passweg J (2009) Diagnosis and treatment of acquired aplastic anemia. Hematol Oncol Clin N Am 23(2):159\u2013170","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"2308_CR15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.13829","volume":"94","author":"P Scheinberg","year":"2009","unstructured":"Scheinberg P, Wu CO, Nunez O, Scheinberg P, Boss C, Sloand EM et al (2009) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 94(3):348\u2013354","journal-title":"Haematologica"},{"issue":"9","key":"2308_CR16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00277-010-0944-y","volume":"89","author":"EH Atta","year":"2010","unstructured":"Atta EH, Dias DS, Marra VL, de Azevedo AM (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol 89(9):851\u2013859","journal-title":"Ann Hematol"},{"issue":"6","key":"2308_CR17","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V95.6.1931","volume":"95","author":"A Bacigalupo","year":"2000","unstructured":"Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F et al (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO\/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 95(6):1931\u20131934","journal-title":"Blood"},{"issue":"19","key":"2308_CR18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","volume":"324","author":"N Frickhofen","year":"1991","unstructured":"Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F et al (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 324(19):1297\u20131304","journal-title":"N Engl J Med"},{"issue":"6","key":"2308_CR19","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood.V96.6.2049","volume":"96","author":"S Kojima","year":"2000","unstructured":"Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H et al (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96(6):2049\u20132054","journal-title":"Blood"},{"issue":"11","key":"2308_CR20","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","volume":"85","author":"SJ Rosenfeld","year":"1995","unstructured":"Rosenfeld SJ, Kimball J, Vining D, Young NS (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85(11):3058\u20133065","journal-title":"Blood"},{"issue":"2","key":"2308_CR21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2141.1999.01693.x","volume":"107","author":"E Bona Di","year":"1999","unstructured":"Di Bona E, Rodeghiero F, Bruno B, Gabbas A, Foa P, Locasciulli A et al (1999) Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol 107(2):330\u2013334","journal-title":"Br J Haematol"},{"issue":"6","key":"2308_CR22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2006.06098.x","volume":"133","author":"P Scheinberg","year":"2006","unstructured":"Scheinberg P, Nunez O, Young NS (2006) Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 133(6):622\u2013627","journal-title":"Br J Haematol"},{"issue":"3","key":"2308_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12185-013-1418-5","volume":"98","author":"T Sakamoto","year":"2013","unstructured":"Sakamoto T, Obara N, Kurita N, Sakata-Yanagimoto M, Nishikii H, Yokoyama Y et al (2013) Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia. Int J Hematol 98(3):319\u2013322","journal-title":"Int J Hematol"},{"issue":"6","key":"2308_CR24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia. Blood 120(6):1185\u20131196","journal-title":"Blood"},{"issue":"6","key":"2308_CR25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00277-013-1674-8","volume":"92","author":"SH Shin","year":"2013","unstructured":"Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS et al (2013) The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol 92(6):817\u2013824","journal-title":"Ann Hematol"},{"issue":"5","key":"2308_CR26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1182\/blood-2012-10-461509","volume":"121","author":"A Yoshimi","year":"2013","unstructured":"Yoshimi A, Niemeyer CM, Fuhrer MM, Strahm B (2013) Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood 121(5):860\u2013861","journal-title":"Blood"},{"issue":"7","key":"2308_CR27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.exphem.2006.03.017","volume":"34","author":"Y Zheng","year":"2006","unstructured":"Zheng Y, Liu Y, Chu Y (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol 34(7):826\u2013831","journal-title":"Exp Hematol"},{"issue":"4","key":"2308_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000321790","volume":"124","author":"H Bing","year":"2010","unstructured":"Bing H, Siyi Y, Wei Z, Jian L, Minghui D, Li J et al (2010) The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine A to treat patients with acquired severe aplastic anemia. Acta Haematol 124(4):245\u2013250","journal-title":"Acta Haematol"},{"issue":"9","key":"2308_CR29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2014.106542","volume":"99","author":"X Feng","year":"2014","unstructured":"Feng X, Scheinberg P, Biancotto A, Rios O, Donaldson S, Wu C et al (2014) In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia. Haematologica 99(9):1433\u20131440","journal-title":"Haematologica"},{"issue":"6","key":"2308_CR30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.exphem.2014.02.003","volume":"42","author":"X Xie","year":"2014","unstructured":"Xie X, Shi W, Zhou X, Shao Y, Qiao X (2014) Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia. Exp Hematol 42(6):431\u2013438","journal-title":"Exp Hematol"},{"issue":"6","key":"2308_CR31","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2006-11-050526","volume":"110","author":"M Teramura","year":"2007","unstructured":"Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A et al (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 110(6):1756\u20131761","journal-title":"Blood"},{"issue":"7","key":"2308_CR32","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood.V93.7.2191","volume":"93","author":"J Marsh","year":"1999","unstructured":"Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S et al (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93(7):2191\u20132195","journal-title":"Blood"},{"issue":"2","key":"2308_CR33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","volume":"144","author":"P Scheinberg","year":"2009","unstructured":"Scheinberg P, Wu CO, Nunez O, Young NS (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144(2):206\u2013216","journal-title":"Br J Haematol"},{"issue":"5","key":"2308_CR34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348","volume":"85","author":"A Bacigalupo","year":"1995","unstructured":"Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A et al (1995) Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85(5):1348\u20131353","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2308-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2308-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T21:26:19Z","timestamp":1598736379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2308-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2308-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,11]]}}}